新诊断上皮性卵巢癌中血清补体激活、中性粒细胞胞外诱捕网及细胞外DNA的预后意义
该两中心前瞻性研究纳入188例新诊断上皮性卵巢癌患者,诊断时采集血液和腹水进行生物标志物分析。多因素分析显示血清gDNA、MPO和CitH3与更差的总生存期相关,而C3b/c无独立关联。探索性分析中低C3b/c且低CitH3患者2年OS为87%,其他患者为46%。
要点
- 血清gDNA、MPO和CitH3在多因素分析中与更差OS独立相关。
- 血清C3b/c在单因素分析中与更差OS相关,多因素分析中无独立关联。
- 腹水中补体负调控因子H升高在单因素分析中与更好OS相关。
核心结论
- 血清gDNA、中性粒细胞胞外诱捕网(NETs)和补体激活可能是新诊断上皮性卵巢癌患者的潜在预后生物标志物。
研究设计与样本
- 两中心前瞻性研究,纳入188例新诊断上皮性卵巢癌患者,诊断时采集血液和腹水进行生物标志物分析,评估无进展生存期(PFS)和总生存期(OS)。
主要发现
- 中位OS为47个月(95%CI:34-58),中位PFS为12个月(95%CI:11-15)。
- 单因素分析中,治疗前血清gDNA、MPO、CitH3和C3b/c水平各自与更差OS相关。
- 控制年龄、分期和理想减瘤的多因素分析中,血清gDNA、MPO和CitH3仍与更差OS相关,而C3b/c水平则无关联。
- 探索性分析中,低C3b/c且低CitH3患者与其他所有患者相比,2年OS差异幅度最大(87% vs 46%)。
- 腹水中补体激活负调控因子H升高在单因素分析中与更好OS相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We observed that the tumor microenvironment (TME) in metastatic epithelial ovarian cancer (EOC) and in other solid tumors can reprogram normal neutrophils to acquire a complement-dependent suppressor phenotype characterized by inhibition of stimulated T cell activation. This study aims to evaluate whether serum markers of neutrophil activation and complement at diagnosis of EOC would be associated with clinical outcomes. EXPERIMENTAL DESIGN: We conducted a two-center prospective study of patients with newly diagnosed EOC (N = 188). Blood and ascites fluid were collected at diagnosis for biomarker analysis. Patients were evaluated for progression-free survival (PFS) and overall survival (OS). RESULTS: The median OS was 47 months (95 % CI: 34-58) and the median PFS was 12 months (95 % CI: 11-15). Pre-treatment serum levels of genomic DNA (gDNA), markers of neutrophil degranulation (myeloperoxidase [MPO]) and neutrophil extracellular traps (NETs) (citrullinated histone H3 [CitH3]), and complement activation (C3b/c) were each associated with worse OS in univariate analysis. In multivariate analyses controlling for age, stage, and optimal debulking, serum gDNA, MPO, and CitH3 remained associated with worse OS, while C3b/c levels were not. In an exploratory analysis, the largest magnitude of difference in 2-year OS occurred in patients with low C3b/c and low CitH3 compared to all other patients (87 % vs 46 % survival, respectively). In ascites fluid, increased factor H, a negative regulator of complement activation, was associated with improved OS in univariate analysis. CONCLUSIONS: These results point to serum gDNA, NETs, and complement activation as potential prognostic biomarkers in patients with newly diagnosed EOC.
引用
- Ricciuti J, Liu Q, Khan ANMNH, et al. Prognostic significance of serum complement activation, neutrophil extracellular traps and extracellular DNA in newly diagnosed epithelial ovarian cancer. Gynecol Oncol. 2025. PMID: 39764857. doi:10.1016/j.ygyno.2024.12.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。